Company Overview and News

 
Looking For Exposure To Silver? Consider Wheaton Precious Metals

2018-04-19 seekingalpha
It looks like the precious metals market is preparing for another leg up. If that is the case, silver should perform better than gold.
Upvote Downvote

 
OR / Osisko Gold Royalties Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-16 sec.gov
Osisko Gold Royalties Ltd. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 Commission File Number: 001
Upvote Downvote

 
Osisko clotûre le financement sur le projet Aurifère Eagle de Victoria Gold

2018-04-16 globenewswire
MONTRÉAL, 16 avr. 2018 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (TSX:OR) (NYSE:OR) (« Osisko ») a le plaisir d’annoncer qu’elle a complété la transaction de financement précédemment annoncée de 148 millions de dollars canadiens (le « financement ») avec Victoria Gold Corp (TSX-V:VIT) (« Victoria ») en vertu de laquelle Osisko a acquis de Victoria une redevance de 5 % du rendement net de fonderie (Net Smelter Return ou « NSR ») (la « redevance ») pour 98 millions de dollars canadiens (l’« acquisition de la redevance ») sur la propriété Dublin Gulch (la « propriété »), qui abrite le projet Eagle Gold (« Eagle » ou le « projet ») situé au Yukon, au Canada (la « redevance »), et a acquis de Victoria, sur la base d’un placement privé, 100 millions d’actions ordinaires de Victoria à un prix de 0,50 $ CA par action ordinaire (le « placement privé »).
Upvote Downvote

 
Osisko Closes Financing on Victoria Gold’s Eagle Gold Project

2018-04-16 globenewswire
MONTRÉAL, April 16, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) (“Osisko”) is pleased to announce that it has completed the previously announced C$148 million financing transaction (the “Financing”) with Victoria Gold Corp. (TSX-V:VIT) (“Victoria”), pursuant to which Osisko acquired from Victoria a 5% net smelter return (“NSR”) royalty (the “Royalty”) for C$98 million (the “Royalty Purchase”) on the Dublin Gulch property (the “Property”) which hosts the Eagle Gold project located in Yukon, Canada, and purchased from Victoria, on a private placement basis, 100 million common shares of Victoria at a price of C$0.
Upvote Downvote

 
Victoria Gold Announces Execution of Definitive Documentation for the Eagle Financing Package and Closing of Equity and Royalty (First Tranche)

2018-04-16 globenewswire
TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Victoria Gold Corp. (TSX:V-VIT) “Victoria” or the “Company” is pleased to announce that it has finalized and executed definitive transaction agreements with Orion Mine Finance (“Orion”), Osisko Gold Royalties Ltd (“Osisko”) and Caterpillar Financial Services Limited (“Cat Financial”) with respect to the previously announced construction financing package totalling approximately C$505 million in aggregate (the “Financing”) that will fully fund the development of the Eagle Gold project through to commercial production.
Upvote Downvote

 
Osisko Metals Announces 17.15 % Zinc+Lead Over 11.0 Metres at Gilmour South

2018-04-11 globenewswire
MONTREAL, April 11, 2018 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V:OM) (FRANKFURT:OB51) is pleased to announce additional results from its drill program on the Gilmour South Project located 40 kilometres southwest of Bathurst, New Brunswick. Drill hole GS-18-19 intersected 13.76% Zn, 3.39% Pb, 0.23% Cu and 50.81g/t Ag over 11.00 metres within the targeted massive sulphide trend that now clearly links previous and historical intercepts not previously interpreted as a continuous zone.
Upvote Downvote

1
Major Issues For Pretium Resources

2018-04-03 seekingalpha
Shares of Pretium Resources have been obliterated over the last few months because of grade reconciliation issues at Brucejack.
Upvote Downvote

 
OR / Osisko Gold Royalties Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-03 sec.gov
Osisko Gold Royalties Ltd. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 Commission File Number: 001
Upvote Downvote

 
Early Warning News Release

2018-04-02 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - April 2, 2018) - Osisko Gold Royalties Ltd (TSX:OR)(NYSE:OR) ("Osisko") announces that it has subscribed for and received from Niobay Metals Inc. (TSX VENTURE:NBY) ("Niobay") 9,000,000 common shares of Niobay at a price of $0.26 per share by way of a private placement of Niobay, for an aggregate subscription price of $2,340,000 (the "Private Placement"').
Upvote Downvote

 
OR / Osisko Gold Royalties Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-03-29 sec.gov
Osisko Gold Royalties Ltd. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2018 Commission File Number: 001
Upvote Downvote

 
OR / Osisko Gold Royalties Ltd. FORM 40-F

2018-03-29 sec.gov
Osisko Gold Royalties Ltd. - Form 40-F - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [ ] Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or [X] Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934
Upvote Downvote

 
Osisko Metals Signs Option Agreement with Osisko Mining on Urban-Barry Base Metal Exploration Claim Group

2018-03-29 marketwired
MONTREAL, QUEBEC--(Marketwired - March 29, 2018) - Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX VENTURE:OM)(FRANKFURT:0B5) is pleased to announce that it has signed an option agreement (the "Agreement") with Osisko Mining Inc (TSX:OSK) to earn a 50% interest in the Urban-Barry Base Metals Project (the "Project"), a select package of 151 claims located within Osisko Mining's Urban-Barry claim group.
Upvote Downvote

 
Niobay Metals announces Closing of Private Placement with Osisko Gold Royalties

2018-03-28 globenewswire
MONTREAL, March 28, 2018 (GLOBE NEWSWIRE) -- Niobay Metals Inc. (“Niobay” or the “Company”) (TSX-V:NBY) is pleased to report that it has closed its previously announced non-brokered private placement with Osisko Gold Royalties Ltd (“Osisko”) (TSX:OR) (NYSE:OR) raising $2,340,000 (the “Financing”).
Upvote Downvote

 
Les Métaux Niobay annonce la clôture d’un placement privé avec Redevances Aurifères Osisko

2018-03-28 globenewswire
MONTRÉAL, 28 mars 2018 (GLOBE NEWSWIRE) -- Les Métaux Niobay inc. (« Niobay » ou la « Société ») (TSX CROISSANCE:NBY) a le plaisir d’annoncer qu’elle a complété, tel que précédemment annoncé, le placement privé sans l’entremise de courtier avec Redevances Aurifères Osisko Ltée (« Osisko ») (TSX:OR) (NYSE:OR) levant 2 340 000 $ (le « Placement Privé »).
Upvote Downvote

 
Strongbow Completes Amendment to South Crofty Share Purchase Agreement

2018-03-28 globenewswire
VANCOUVER, British Columbia, March 28, 2018 (GLOBE NEWSWIRE) -- Strongbow Exploration Inc. (TSX-V:SBW) (“Strongbow” or the “Company”) is pleased to announce that, pursuant to the Share Purchase Agreement (“SPA”) announced March 17, 2016, regarding the acquisition of the South Crofty tin project, the Company, Galena Special Situations Master Fund Limited (“Galena”), and Tin Shield Production Inc (“Tin Shield”) have entered into a Side Letter to the SPA, whereby the remaining payments due to Galena and Tin Shield can be amended to allow Strongbow to remove certain share issuances and/or cash payments due on delivery of feasibility and/or a production decision to Galena and Tin Shield, provided that the Company’s shares are listed on AIM before the end of 2018, in return for the following:
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 68827L952